Cognition Therapeutics Inc
CGTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001455365
No open-market purchases or sales by Cognition Therapeutics Inc insiders were filed in the last 90 days; 66 institutions reported holding it in 13F filings for Q2 2026, worth $26.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Cognition Therapeutics Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +20 vs. Q3 2021
- Shares held
- 1.33M
- +1.33M vs. Q3 2021
- Total value
- $8.44M
- +$8.44M vs. Q3 2021
- New holders
- 20
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $26.0M |
| Q1 2026 | 75 | $16.3M |
| Q4 2025 | 78 | $28.9M |
| Q3 2025 | 68 | $28.7M |
| Q2 2025 | 48 | $3.50M |
| Q1 2025 | 51 | $4.89M |
| Q4 2024 | 45 | $7.78M |
| Q3 2024 | 40 | $1.99M |
| Q2 2024 | 46 | $8.82M |
| Q1 2024 | 47 | $12.9M |
| Q4 2023 | 37 | $13.2M |
| Q3 2023 | 36 | $10.4M |
| Q2 2023 | 35 | $13.0M |
| Q1 2023 | 32 | $14.1M |
| Q4 2022 | 34 | $10.1M |
| Q3 2022 | 31 | $9.67M |
| Q2 2022 | 28 | $11.4M |
| Q1 2022 | 27 | $4.58M |
| Q4 2021 | 20 | $8.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Cognition Therapeutics Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prosight Management, LP | 301,979 | $1.91M | 1.27% | +301,979 | New |
| Nantahala Capital Management, LLC | 209,588 | $1.32M | 0.08% | +209,588 | New |
| American Financial Group Inc | 205,000 | $1.30M | 0.35% | +205,000 | New |
| P.A.W. Capital Corp | 100,000 | $632.0K | 0.58% | +100,000 | New |
| Kestra Advisory Services, LLC | 95,112 | $601.0K | 0.01% | +95,112 | New |
| Two Sigma Investments, LP | 83,398 | $527.0K | 0.00% | +83,398 | New |
| Two Sigma Advisers, LP | 68,900 | $435.0K | 0.00% | +68,900 | New |
| Vanguard Group Inc | 58,579 | $371.0K | 0.00% | +58,579 | New |
| Millennium Management LLC | 56,419 | $357.0K | 0.00% | +56,419 | New |
| B. Riley Financial, Inc. | 30,904 | $195.0K | 0.02% | +30,904 | New |
| Rock Creek Group, LP | 26,439 | $167.0K | 0.02% | +26,439 | New |
| Voss Capital, LLC | 26,439 | $167.0K | 0.05% | +26,439 | New |
| AIGH Capital Management LLC | 25,496 | $161.0K | 0.05% | +25,496 | New |
| New York Life Investments Alternatives | 22,691 | $143.0K | 0.10% | +22,691 | New |
| Renaissance Technologies LLC | 11,764 | $74.0K | 0.00% | +11,764 | New |
| BlackRock Inc. | 7,997 | $51.0K | 0.00% | +7,997 | New |
| UBS Group AG | 3,749 | $24.0K | 0.00% | +3,749 | New |
| Bray Capital Advisors | 250 | $2.00K | 0.00% | +250 | New |
| Royal Bank of Canada | 100 | $1.00K | 0.00% | +100 | New |
| Wells Fargo & Company | 24 | $0 | 0.00% | +24 | New |